Sab Biotherapeutics Files Prospectus Related To Up To 14.7 Million Shares Of Common Stock That Selling Stockholders May Sell
SAB Biotherapeutics Inc SABS:
SAB BIOTHERAPEUTICS FILES PROSPECTUS RELATED TO UP TO 14.7 MILLION SHARES OF COMMON STOCK THAT SELLING STOCKHOLDERS MAY SELL - SEC FILING